| 278P Plasmid encoding p62/SQSTM1 administered in combination with CMF chemotherapy improves outcomes in metastatic triple-negative breast cancer patients S Krasny, S Polyakov, E Zhavrid, A Khorau, Y Baranau, S Kozlovskaya, ... Annals of Oncology 32, S485, 2021 | 1 | 2021 |
| 538P Adding plasmid encoding p62/SQSTM1 to gemcitabine chemotherapy increases PFS for patients with platinum-resistant ovarian cancer (updated data) Y Baranau, S Polyakov, V Gabai, K Zharkova, A Filimonava, V Siarheyeva, ... Annals of Oncology 33, S794, 2022 | | 2022 |
| 759P Adding dosing of plasmid encoding p62/SQSTM1 to gemcitabine chemotherapy may provide clinical benefits to patients with platinum-resistant ovarian cancer S Polyakov, S Krasny, E Zhavrid, Y Baranau, O Sergeeva, K Zharkova, ... Annals of Oncology 32, S747-S748, 2021 | 3 | 2021 |
| Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent preB cell apoptosis. K Yamaguchi, RI Near, RA Matulka, A Shneider, P Toselli, AF Trombino, ... Journal of immunology (Baltimore, Md.: 1950) 158 (5), 2165-2173, 1997 | 81 | 1997 |
| Adjuvant potential of aggregate-forming polyglutamine domains PO Ilyinskii, G Thoidis, MY Sherman, A Shneider Vaccine 26 (26), 3223-3226, 2008 | 29 | 2008 |
| Apparatus and methods for chemical and biochemical sample preparation A Shneider, Y Katsman US Patent App. 11/052,425, 2006 | 8 | 2006 |
| Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector MY Sherman, VL Gabai, A Chursov, A Shneider | | |
| Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector F Venanzi, V Shifrin, MY Sherman, V Gabai, O Kiselev, A Komissarov, ... Oncotarget 4 (10), 1829, 2013 | 41 | 2013 |
| Can melatonin reduce the severity of COVID-19 pandemic? A Shneider, A Kudriavtsev, A Vakhrusheva International reviews of immunology 39 (4), 153-162, 2020 | 233 | 2020 |
| Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial S Krasny, Y Baranau, S Polyakov, E Zharkova, O Streltsova, A Filimonava, ... Frontiers in Oncology 14, 1343023, 2024 | | 2024 |
| Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 … SE Aleshin, AV Timofeev, MV Khoretonenko, LG Zakharova, ... BMC microbiology 5, 1-5, 2005 | 34 | 2005 |
| Compositions and Methods Relating to p62 for the Treatment and Prophylaxis of Age-Related Macular Degeneration A Shneider, M Sherman, V Gabai, N Kolosova, O Kozhevnikova US Patent App. 17/265,516, 2021 | 1 | 2021 |
| Computational Discovery of Evolutionary Conserved Enterovirus 71 RNA Secondary Structures N Fridlyand, AN Lukashev, A Chursov, FM Venanzi, JW Yewdell, ... bioRxiv, 495507, 2018 | | 2018 |
| Conservation of mRNA secondary structures may filter out mutations in Escherichia coli evolution A Chursov, D Frishman, A Shneider Nucleic acids research 41 (16), 7854-7860, 2013 | 30 | 2013 |
| Development of a vaccine against pandemic influenza viruses: current status and perspectives PO Ilyinskii, G Thoidis, AM Shneider International Reviews of Immunology 27 (6), 392-426, 2008 | 17 | 2008 |
| Effective expression of recombinant cytotoxic protein via its attachment to a polyglutamine domain PO Ilyinskii, MV Nurminskaya, VL Gabai, AG Prilipov, EV Usachev, ... OMICS A Journal of Integrative Biology 13 (3), 211-217, 2009 | | 2009 |
| Effects of the baseline prognostic factors on efficacy of the p62/SQSTM1-encoding plasmid combined with gemcitabine in patients with recurrent platinum-resistant ovarian cancer. A Shneider, S Polyakov, Y Baranau, V Gabai, E Zharkova, O Streltsova, ... Journal of Clinical Oncology 41 (16_suppl), e17540-e17540, 2023 | 1 | 2023 |
| Expression of the aryl hydrocarbon receptor is regulated by serum and mitogenic growth factors in murine 3T3 fibroblasts C Vaziri, A Schneider, DH Sherr, DV Faller Journal of Biological Chemistry 271 (42), 25921-25927, 1996 | 66 | 1996 |
| Fluoranthene-induced apoptosis in murine T cell hybridomas is independent of the aromatic hydrocarbon receptor K Yamaguchi, R Near, A Shneider, H Cui, ST Ju, DH Sherr Toxicology and applied pharmacology 139 (1), 144-152, 1996 | 56 | 1996 |
| Four stages of a scientific discipline; four types of scientist AM Shneider Trends in biochemical sciences 34 (5), 217-223, 2009 | 209 | 2009 |
